October is #MentalHealthAwarenessMonth! Here at PepGen, we hosted a screening of the movie "Brothers" created by Michael Norton which tells the story of his family's #DMD experience and their mental health challenges.
Clinical trials can be difficult to navigate if you aren’t familiar with all the terms. That’s why #ProfessorPepGen is here to help you brush up on your clinical trial lingo with “Lesson 3: The Clinical Trial Dictionary.” #PatientEducation#Advocacy#ClinicalTrials
We hosted Ashley and Jesse Segovia, Jeannine DeSoi, and Dr. Thurman Wheeler for a #DM1 lunch and learn last week. Our PepGen pioneers learned about DM1 from the unique perspectives of a physician, community members, and a caregiver.
📊🔬Don't miss our "Meet the #MyotonicDystrophy Drug Developer" session with PepGen! 📽️👇 Watch the recording & discover the latest advancements on their PGN-EDODM1 program at https://t.co/1qfo4B4OLc
@MyotonicStrong named July #MyotonicDystrophy#inMotion Awareness Month! PepGen hosted a lunch & learn highlighting recent data on the benefits of exercise for DM1 and a yoga class for staff. For more info visit: https://t.co/pyGC38DyNK
@PepGenTx has shared positive data from the 1st dose cohort (5 mg/kg) of PGN-EDO51, the company’s lead investigational candidate for patients with #Duchenne whose mutations are amenable to exon 51-skipping.
Learn more: https://t.co/JbVX9Yam9W
🗓️ Join us on Aug 2nd for a Meet the #myotonicDystrophy Drug Developers webinar and Q&A with @PepGen! 💊 Discover their latest DM program advancements. 🚀 Don't miss out - sign up now! 👇 https://t.co/M68T1Vh6LZ
PepGen invites you to “Meet the #MyotonicDystrophy Drug Developers” webinar hosted by @mytonicstrong on Tuesday, August 2nd. The webinar will be about PGN-EDODM1 and our clinical program. To register visit https://t.co/Pp700tNn2I
At the IDMC-14 Myotonic Dystrophy Meeting, Stichting MD created a video titled 'What’s Happening Now,' with the DM1 community on what matters most. Listen to insights from participants in the video below. #MyotonicDystrophy#Awareness#Advocacy https://t.co/5klgDYdwAr
Are you or a family member living with Duchenne muscular dystrophy? Our clinical research study is now enrolling. To learn more visit https://t.co/5tYLHEEWRG
We are on track to report preliminary data from the 5 mg/kg cohort of CONNECT1 in DMD mid-year. This will be followed with preliminary data from the higher 10 mg/kg dose cohort, further advancing our goal of transforming the treatment landscape for DMD.
https://t.co/R5i3AW8oRL
PepGen thanks @CureDuchenne for the opportunity to join the #DMD community at the #FUTURES conference. We always feel privileged to engage with advocates, families, researchers, and clinicians in meaningful discussions on how we can support the DMD community.
Thank you to everyone who shared their memories with us over the last few days! Enjoy this little collection of clips sent our way by members of the Canadian #Duchenne#musculardystrophy community.
You can recap the day here: https://t.co/kUd1uFDO7v.
PepGen is appreciative of @DefeatDuchenne and all those who tuned in for our webinar last week. If you missed it, check it out: https://t.co/ylc4Ut7wgR
#Duchenne#musculardystrophy